Structural deflationary impact proprietary Chinese medicine export

On June 17, 2016

Business club

In the first quarter of this year, the global economy general "low growth, low inflation, high uncertainty" characteristics. General weak recovery in the developed countries, at the same time, influenced by structural deflation, decline in growth in emerging economies, so that China's traditional export a declining state, also exports to $52.7558 million in the first quarter, down 12.96% year-on-year.

The association of south-east Asian nations (asean) is the main

In addition to the association of south-east Asian nations (asean) and Latin America market growth, the rest of the market. Proprietary Chinese medicine exports are down.

Regions of Hong Kong, China and the association of south-east Asian nations (asean) is still a proprietary Chinese medicine, the main export market accounted for 60.14% of the whole traditional exports; In the first quarter this year, our country in the Middle East's traditional exports was $1.3972 million, fell by 28.58%, 2.65%; Exports to Africa to $3.6471 million, fell by 15.81%, 6.91%; For Europe's exports was $3.0748 million, fell by 8.76%, 5.83%; Exports to Latin America was $1.2429 million, increased 4.35% year-on-year, 2.36%; Exports to North America for $4.2904 million, fell by 14.91%, 8.13%; Exports of Oceania was $2.1918 million, fell by 16.17%, 4.15%.

A total of 324 in the first quarter of this year China's traditional export enterprises, the state-owned enterprises has been the main force to promote proprietary Chinese medicine export, but export quotas in a declining trend, in 2012, exports accounted for 56.86%, fell to 43.49% in 2013, 37.92% in 2014, 2015 (39.67%); In the first quarter of China's traditional export number of private enterprises in 243, exports of $17.498 million, fell 12.27% year on year, accounted for 33.17%; Foreign invested enterprises to export number for 27, exports was $13.7191 million, fell 23.05% year on year, exports accounted for 26%.

The road of internationalization is very long

Traditional Chinese medicine (TCM) to really enter the international market is still a long way to go. To some extent, proprietary Chinese medicine export situation can be seen as a "barometer" of the internationalization of Chinese medicine. Have been climbing steadily since 2000, proprietary Chinese medicine export, export flat in 2012 and 2013, China's traditional exports to $2014 in 250 million, down 6.25% year-on-year, proprietary Chinese medicine in our country exports to $2015 in 260 million, up 5.64% year-on-year.

Our government has been advocating traditional Chinese medicine "to the world", is emerging in the industry tongren temple, tasly, such as a large number of outstanding enterprises, set up the chain, image store in overseas, with a kind of new marketing model took Chinese medicine health care products to all over the world.

On May 24, 2014, who convened the 67th world health assembly review and passed the resolution of traditional medicine, urge each member according to the actual situation, adjust, adoption and implementation of the who traditional medicine strategy in 2014-2013 ", its traditional medicine planning or work plan, develop national policies, standards and regulations, strengthen the ability construction, the development of traditional medicine. "Strategic" determines the established traditional medicine information, to provide support for national policy; To strengthen supervision, ensure the quality of traditional medicine products and services, security, appropriate use and effectiveness. Promote the traditional universal coverage of medical services and other three goals, made clear the development of the next 10 years the strategic direction and action.

And Chinese medicine and health products import and export chamber of commerce, vice President liu zhang Lin admitted that internationalization of traditional Chinese medicine is the only way for every one Chinese medicine enterprises have to face, traditional Chinese medicine (TCM) to obtain in the international market and its considerable recognition in China, there is still a long way to go.

(article source: medicine economic news)